https://www.selleckchem.com/pr....oducts/zebularine.ht
001), White (p = 0.002), and have a good predicted performance status (p less then 0.001). Patients who saw all three specialist types (medical oncologist, radiation oncologist, and surgeon) had increased odds of receiving cCRT (p less then 0.001). ST and RT patients had higher mortality risk versus cCRT patients (hazard ratio [95% CI] ST 1.38 [1.26-1.51]; RT 1.75 [1.61, 1.91]); p less then 0.001). CONCLUSIONS Several factors contributed to treatment selection, including patient age and health status, and whether the patient received
Мне нравится
Комментарий
Перепост
